Protein D Carrier Protein

About Scarab Genomics

Scarab Genomics leverages synthetic biology to create optimized bacterial production platforms and essential biopharmaceutical components. Its flagship technology is the Clean Genome® E. coli, a reduced-genome strain offering enhanced genetic stability and metabolic efficiency for producing proteins and plasmid DNA. The company generates revenue through product sales of strains, vectors, and carrier proteins (CRM197, Protein D), as well as through licensing agreements and partnerships, positioning it as a key enabler for vaccine developers and biomanufacturers.

Therapeutic Areas

Other Vaccine Component (Conjugate Vaccines) Drugs